Literature DB >> 28411689

Moutan Cortex and Paeoniae Radix Rubra reverse high-fat-diet-induced metabolic disorder and restore gut microbiota homeostasis.

Ling-Jun Zhong1, Zhi-Sheng Xie1, Hua Yang1, Ping Li2, Xiao-Jun Xu3.   

Abstract

The present study was designed to investigate the therapeutic effcts of Moutan Cortex (CM, root bark of Paeonia suffruticosa Andr) and Paeoniae Radix Rubra (PR, root of Paeonia veitchii Lynch) on metabolic disorders, focusing on the infuence of CM and PR on the obesity-related gut microbiota homeostasis. The diet-induced obese (DIO) mouse model was used to test the therapeutic effects of CM and PR. The mice were orally administered with CM and PR for 6 weeks, and oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) were performed to evaluate the insulin sensitivity of the mice. Sterol-regulatory element binding proteins (SREBPs) and their target genes were measured by quantitative RT-PCR. High-throughput 16S ribosomal RNA (16S rRNA) gene sequencing technology was used to determine the composition of gut microbiota, and the metabolites in serum were analyzed by GC-MS. Our results indicated that CM and PR combination alleviated obese and insulin resistance in the DIO mice, leading to increased glucose uptake and gene expression in muscle and liver, and down-regulated SREBPs and their target genes in liver. Interesting, neither the CM-PR extracts, nor the major components of CM and PR did not affect SREBPs activity in cultured cells. Meanwhile, CM and PR significantly modulated the gut microbiota of the high-fat diet (HFD) treated mice, similar to metformin, and CM-PR reversed the overall microbiota composition similar to the normal chow diet (NCD) treated mice. In conclusion, our results provide novel mechanisms of action for the effects of CM and PR in treating DIO-induced dysregulation of sugar and lipid metabolism.
Copyright © 2017 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gut microbiota; Insulin resistance; Moutan Cortex; Paeoniae Radix Rubra

Mesh:

Substances:

Year:  2017        PMID: 28411689     DOI: 10.1016/S1875-5364(17)30037-7

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  6 in total

Review 1.  Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.

Authors:  Junli Ma; Qihang Zhou; Houkai Li
Journal:  Nutrients       Date:  2017-10-16       Impact factor: 5.717

2.  Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH.

Authors:  Mona A Hegazy; Sherif M Mogawer; Alshaimaa Rezk L R Alnaggar; Olfat A Ghoniem; Rasha M Abdel Samie
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-20       Impact factor: 3.168

3.  Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease.

Authors:  Bo Liang; Xiao-Xiao Zhang; Ning Gu
Journal:  BMC Complement Med Ther       Date:  2020-11-13

4.  Jian-Gan-Xiao-Zhi Decoction Alleviates Inflammatory Response in Nonalcoholic Fatty Liver Disease Model Rats through Modulating Gut Microbiota.

Authors:  Jiabao Liao; Xuehua Xie; Jinmei Gao; Zhaiyi Zhang; Fei Qu; Huantian Cui; Yongjun Cao; Xue Han; Jie Zhao; Weibo Wen; Hongwu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-20       Impact factor: 2.629

5.  Paeonol suppresses lipid formation and promotes lipid degradation in adipocytes.

Authors:  Ji Li; Huan Gu
Journal:  Exp Ther Med       Date:  2021-11-25       Impact factor: 2.447

6.  An Ethnopharmaceutical Study on the Hypolipidemic Formulae in Taiwan Issued by Traditional Chinese Medicine Pharmacies.

Authors:  Min-Han Chi; Jung Chao; Chien-Yu Ko; Shyh-Shyun Huang
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.